Pipeline
iO Bio’s pipeline has an initial clinical focus in oncology and in particular liver cancer.
|
|
Discovery |
Preclinical |
In-House |
|
|
In-License: Liver Cancer |
|
|
In License: Pan-Cancer |
|
|
Partnering
We seek partners interested in using our GEMS™ technology to develop an off-the-shelf CAR therapy portfolio. iO BiO’s technology is ideally suited to rapidly convert autologous CARs into an off-the-shelf CAR portfolio with any universal cell
Vision for GEMS™
iO BiO Sciences Investors
Contact Sicco Popma for investment opportunities
